Vestcor Inc Buys 2,120 Shares of Chemed Corporation $CHE

Vestcor Inc grew its stake in shares of Chemed Corporation (NYSE:CHE) by 59.4% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 5,689 shares of the company’s stock after purchasing an additional 2,120 shares during the period. Vestcor Inc’s holdings in Chemed were worth $2,434,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CHE. Geneos Wealth Management Inc. increased its holdings in Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in Chemed by 67.0% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock worth $5,534,000 after purchasing an additional 4,560 shares in the last quarter. Marshall Wace LLP bought a new stake in Chemed during the 2nd quarter worth approximately $579,000. Brown Advisory Inc. increased its holdings in Chemed by 36.9% during the 2nd quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock worth $267,000 after purchasing an additional 148 shares in the last quarter. Finally, Cerity Partners LLC increased its holdings in Chemed by 237.7% during the 2nd quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock worth $2,165,000 after purchasing an additional 3,133 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the transaction, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 3.33% of the company’s stock.

Chemed Price Performance

Shares of NYSE CHE opened at $440.67 on Monday. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $565.66. The stock’s 50 day moving average price is $409.41 and its 200-day moving average price is $424.51. The company has a market capitalization of $5.85 billion, a PE ratio of 24.01, a PEG ratio of 1.66 and a beta of 0.54. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11.

Chemed (NYSE:CHE) last announced its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. During the same quarter in the previous year, the business earned $5.63 EPS. The company’s revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, equities analysts anticipate that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Thursday, May 28th will be paid a $0.60 dividend. The ex-dividend date is Thursday, May 28th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s dividend payout ratio is presently 13.08%.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on CHE shares. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research note on Monday. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Royal Bank Of Canada boosted their target price on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research note on Monday, April 27th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Finally, Oppenheimer cut their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research note on Friday, February 27th. Two analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $501.50.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.